Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatment

Zago, Manola; Oehrlein, Katharina; Rendl, Corinna; Hahn-Ast, Corinna; Kanz, Lothar; Weisel, Katja

dc.contributor.author	Zago, Manola
dc.contributor.author	Rendl, Corinna
dc.contributor.author	Kanz, Lothar
dc.contributor.author	Weisel, Katja
dc.contributor.author	Oehrlein, Katharina Barbara
dc.date.accessioned	2015-03-20T14:15:51Z
dc.date.available	2015-03-20T14:15:51Z
dc.date.issued	2014
dc.identifier.issn	0939-5555
dc.identifier.uri	http://hdl.handle.net/10900/60522
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00277-014-2149-2	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatment	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150115224006_00168	de_DE
utue.publikation.seiten	1993-1999	de_DE
utue.personen.roh	Zago, Manola
utue.personen.roh	Oehrlein, Katharina
utue.personen.roh	Rendl, Corinna
utue.personen.roh	Hahn-Ast, Corinna
utue.personen.roh	Kanz, Lothar
utue.personen.roh	Weisel, Katja
dcterms.isPartOf.ZSTitelID	Annals of Hematology	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	93	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE